Results

Total Results: 944 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

281. Screening for Anxiety in Children and Adolescents: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/oZSntFpszryu7mAnjdhkrw
     September 05, 2023 - , adverse events. … Outcomes reported include (1) suicide-related harms, (2) with- drawal due to adverse events, (3) and … serious adverse events. … Regarding withdrawal due to adverse events, the pooled RR for CBT trials was 0.39 (95% CI, 0.08 to 1.87 … The evidence suggests that suicide- related harms, serious adverse events, and withdrawal due to ad-

282. Screening for Hypertension in Children and Adolescents: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RcckGKJEfBSus5YG89yVpt
     November 10, 2020 - For effectiveness, hypertension- related health outcomes (eg, cardiovascular events, end-stage kid- ney … Pharmacological Treatments Combined With Lifestyle Interventions No differences in adverse events were … events between pharmacological treatments (β-blocker, calcium channel blockers, ACE inhibitors, or ARBs … events between pharmacological treatment (propranolol + chlorothalidone) plus lifestyle interventions … direct evidence regarding the association between childhood hypertension and adult car- diovascular events

283. Screening for Lipid Disorders in Children: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/BwAo_shwmJLSRguyWxaXpP
     July 01, 2007 - Adverse effects from lipid-lowering medications and low-fat diets, including potential long-term harms … abnormal lipid levels have been strongly associated with the risk of coronary heart disease (CHD) events … reduction in 4 studies). 2 Harms of Screening and Treatment There is poor-quality evidence on the adverse … treatment is based on 81 controlled and non-controlled studies of treatment that reported a variety of adverse … The adverse effects of long-term use of lipid-lowering agents (eg, >20 years) have not been studied.

284. Jepnfupw Kyd7Nhaf-To62
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JEpnfupw_kyd7Nhaf-to62
     October 11, 2022 - , adverse events. … Outcomes reported include (1) suicide-related harms, (2) with- drawal due to adverse events, (3) and … serious adverse events. … Regarding withdrawal due to adverse events, the pooled RR for CBT trials was 0.39 (95% CI, 0.08 to 1.87 … The evidence suggests that suicide- related harms, serious adverse events, and withdrawal due to ad-

285. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/N5p-_zPoFQTZTvZCooqrR8
     June 12, 2020 - There were no significant differences in risk of serious adverse events (RR, 1.14 [95% CI, 0.60-1.99] … ; I2 = 32%; 3 trials; n = 3140), withdrawal due to adverse events (RR, 2.40 [95% CI, 0.71-19.32]; I2 … = 0%; 5 trials; n = 648), or any adverse event (RR, 1.56 [95% CI, 0.59-4.03]; I2 = 82%; 2 trials; n = … 1538).7,16 Two trials found that treatment was associated with increased risk of ocular adverse events … and serious adverse events.

286. Draft Recommendation: Intimate Partner Violence and Caregiver Abuse of Older or Vulnerable Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/intimate-partner-violence-abuse-older-vulnerable-adults
     October 29, 2024 - with the control group. 1 In one study, IPV victimization was lower in the intervention group (7.50 events … per person-year) compared with the control group (9.55 events per person-year) at 3 years, but the difference … was not statistically significant (incident rate ratio of average IPV events per person-year, 0.86 [ … events; however, it was unclear whether events were prespecified or how they were monitored. 1 , 51 … events related to study participation by women. 1 , 49 Other trials also reported no harms associated

287. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
     June 20, 2019 - benefit from risk-reducing medications for breast cancer, as well as evidence on the effectiveness, adverse … , or aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse … , or aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse … Vasomotor symptoms (hot flashes) are a common adverse effect of both medications. … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.

288. Archived: Evidence Summary: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary28/cognitive-impairment-in-older-adults-screening-2014
     October 22, 2013 - However, total serious adverse events did not seem to differ for these medications across trials with … The definitions of serious adverse events were not commonly described in the included studies. … Observational studies suggest that bradycardia and adverse events related to it (for example, fall or … Only 1 of the included trials mentioned harms, and it found no adverse events in either group. … events are CNS, heart rate/rhythm, and gastrointestinal disorders and that bradycardia and adverse events

289. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - , or aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse … potential benefit of risk reduction of breast cancer must be balanced against the potential harms of adverse … Vasomotor symptoms (hot flashes) are a common adverse effect of both medications. … benefit from risk-reducing medications for breast cancer, as well as evidence on the effectiveness, adverse … Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.

290. Archived: Final Evidence Summary: Obesity in Adults: Screening and Management | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
     October 15, 2011 - events into standardized evidence tables 9 . … events ( Table 2) 22 , 83 , 102 . … No studies reported serious adverse effects. … Meridia (sibutramine): market withdrawal due to risk for serious cardiovascular events. … The figure also depicts the possibility of harms or adverse events occurring as a result of screening

291. Draft Recommendation: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/obstructive-sleep-apnea-adults-screening
     March 29, 2022 - Severe OSA is associated with increased all-cause mortality. 2 , 3 In addition to mortality, other adverse … In general, mild OSA is defined as five to 15 events per hour, moderate OSA as 16 to 30 events per hour … devices (MADs) are an alternative therapy to PAP for patients with OSA who prefer them or for those with adverse … is primarily attributed to the increase in prevalence of obesity. 1 OSA is associated with multiple adverse … due to few studies with few events and inadequate followup.

292. Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6L2obA88s86MoZDbWtMPTU
     December 01, 2011 - Vitamin D with or without calcium supplementation vs. placebo Adverse events All 63 RCTs included … events and were not adequately powered to detect adverse events. 1 RCT in postmenopausal women (n � … Adverse Events Associated With Vitamin D With or Without Calcium The Women’s Health Initiative trial … events and were not adequately powered to detect adverse events. … However, these adverse events may or may not be associated with the vitamin D or calcium supplements.

293. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DCfAJZvNDzSYu7NqLJX2bv
     March 01, 2016 - - ment use vs placebo in risk of any adverse events (93% vs 89%; RR, 1.05; 95% CI, 0.97-1.13), serious … adverse events (31% vs 30%; RR, 1.04; 95% CI, 0.72-1.49), or serious ocular adverse events (8.2% vs … events, but estimates for those outcomes were imprecise. … events in participants taking zinc vs placebo. … No increase in risk of systemic hypertension or arterial thromboembolic events.

294. Archived: Evidence Summary: Osteoporosis: Screening 2011 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary6/osteoporosis-screening-2011
     July 06, 2010 - Bisphosphonates are not consistently associated with serious adverse events; raloxifene and estrogen … increase thromboembolic events; and estrogen causes additional adverse events. … differences with placebo in rates of serious gastrointestinal adverse events 107 , 108 or withdrawals … events. … Upper gastrointestinal adverse events and cyclical etidronate. Am J Med 1997;103:462-7.

295. Final Recommendation Statement: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd
     November 24, 2020 - . 11 , 16 Twelve of these trials reported cardiovascular events, and among the trials with a composite … reviewed by the USPSTF, only 20 specifically reported on harms, and 8 of these specifically reported no adverse … events. 11 , 16 Few trials reported details about the adverse events, but most were minor. … Serious adverse events were rare. 11 , 16 There was no consistent evidence that behavioral counseling … Large replication studies of interventions showing reductions in CVD events are urgently needed.

296. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vmHooQ6ABG9CagdUXv2_rx
     August 25, 2021 - There were no significant differences in Tanner staging or hormonal adverse events between statin and … years of follow-up in indi- viduals taking statins compared with control groups.1,17 Studies reporting adverse … tervention trial did not mention harms, and the 3 supplement trials for FH reported that there were no adverse … Dyslipidemia In studies including individuals with FH or multifactorial dyslipid- emia, gastrointestinal adverse … Childhood cardiovascular risk factors and adult cardiovascular events.

297. Screening for Cardiovascular Disease Risk With Electrocardiography: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/meNqyNxrVyw_U4jdcrx3A2
     January 01, 2020 - Possible harms are associated with screening with resting or exercise ECG, specifically the potential adverse … in asymptomatic adults at low risk of CVD events. … in asymptomatic adults at intermediate or high risk of CVD events. … but might also result in harms, including adverse medication effects such as gas- trointestinal bleeding … possible harms are associated with screening with resting or exercise ECG, specifically the potential adverse

298. Draft Research Plan: Screening for Colorectal Cancer | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/colorectal-cancer-screening3
     January 03, 2019 - including but not limited to: perforation, major bleeding, severe abdominal symptoms, and cardiovascular events … ; extracolonic findings, subsequent diagnostic workup, and adverse events from diagnostic testing for

299. Archived: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening-september-2016
     September 06, 2016 - A few studies also reported on gastrointestinal adverse events. … nonsignificant increased RR of gastrointestinal adverse events (RR, 1.60 [95% CI, 0.76 to 3.40]) in … 2 studies. 2  All 5 studies also reported on discontinuation of treatment because of adverse events. … events. … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

300. Screening for Bacterial Vaginosis in Pregnant Adolescents and Women to Prevent Preterm Delivery: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/BjVjF4sgsZovQbK7CEzaZL
     April 07, 2020 - Maternal adverse events from treatment were infrequent and minor (eg, candidiasis) but were slightly … Maternal adverse events from treatment appear to be infrequent and minor, but the evidence about harms … Eight RCTs reported on maternal adverse events,45,48,49,51,52,55-57 and 6 stud- ies reported on adverse … during pregnancy (KQ4), 8 (n = 7758) reported on maternal adverse events. … Adverse events from intravaginal clindamycin were infrequent and mild (eg, vaginal itching).Fi gu re